French study tracks COVID-19's toll on pregnant women and their babies

NCT ID NCT04463758

First seen Jul 01, 2026 · Last updated Jul 01, 2026

Summary

This study follows thousands of pregnant women in France who had or likely had COVID-19 during pregnancy or shortly after giving birth. Researchers track health problems in both mothers and newborns up to 12 weeks after delivery, using medical records and questionnaires about mental health. The goal is to better understand how COVID-19 affects pregnancy and newborn outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better understand and manage COVID-19 risks during pregnancy, improving care for mothers and babies.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may not apply to all populations or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 Perinatal Death pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AP-HP Cochin

    Paris, 75014, France